Hokkaido Cancer Center

Sapporo, Hokkaido 003-0804

0 studies enrolling now · 2 studies all time

What they study most

Liposarcoma, Dedifferentiated

Studies at this site

• Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma — Completed
• Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma — Completed